Leptin: The link between overweight and primary hyperparathyroidism?

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 94-96

  Cheng, Shih Ping ^a   Doherty, Gerard M ^b   Chang, Yuan Ching ^a,c   Liu, Chien Liang ^a,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LEPTIN; PARATHYROID HORMONE; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; DISEASE ASSOCIATION; ENERGY EXPENDITURE; HUMAN; INSULIN BLOOD LEVEL; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIMARY HYPERPARATHYROIDISM; PROTEIN FUNCTION; SEX DIFFERENCE;

ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LEPTIN; OVERWEIGHT;

MUS;

EID: 78650171122     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.039     Document Type: Article

References (32)

1. Lundgren E., Rastad J., Thrufjell E., Akerstrom G., Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997, 121:287-294.
2. Westin G., Bjorklund P., Akerstrom G. Molecular genetics of parathyroid disease. World J Surg 2009, 33:2224-2233.
3. Farnebo F., Kytola S., Teh B.T., Dwight T., Wong F.K., Hoog A., et al. Alternative genetic pathways in parathyroid tumorigenesis. J Clin Endocrinol Metab 1999, 84:3775-3780.
4. Saunders B.D., Saunders E.F., Gauger P.G. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg 2009, 33:2314-2323.
5. Miller B.S., Dimick J., Wainess R., Burney R.E. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 2008, 32:795-799.
6. Bolland M.J., Grey A.B., Gamble G.D., Reid I.R. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005, 90:1525-1530.
7. Shaw J.H., Croxon M., Holdaway I., Collins J.P., Wolfe R.R. Glucose, fat, and protein kinetics in patients with primary and secondary hyperparathyroidism. Surgery 1988, 103:526-532.
8. Richards M.L., Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy?. Surgery 1999, 126:1160-1166.
9. Hagstrom E., Lundgren E., Lithell H., Berglund L., Ljunghall S., Hellman P., et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 2002, 56:253-260.
10. Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond) 2008, 32(Suppl. 6):S62-S71.
11. Grey A., Reid I. Body weight and bone mineral density in hyperparathyroidism. Ann Intern Med 1995, 123:732.
12. Pitt S.C., Panneerselvan R., Sippel R.S., Chen H. Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidism. Am J Surg 2010, 199:410-415.
13. Hamoui N., Anthone G., Crookes P.F. Calcium metabolism in the morbidly obese. Obes Surg 2004, 14:9-12.
14. Bolland M.J., Grey A.B., Ames R.W., Horne A.M., Gamble G.D., Reid I.R. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 2006, 38:317-321.
15. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
16. Delfini E., Petramala L., Caliumi C., Cotesta D., De Toma G., Cavallaro G., et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 2007, 56:30-36.
17. Maetani M., Maskarinec G., Franke A.A., Cooney R.V. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer 2009, 61:225-231.
18. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009, 297:E1247-E1259.
19. Whitfield J.F. Parathyroid hormone and leptin - new peptides, expanding clinical prospects. Expert Opin Investig Drugs 2005, 14:251-264.
20. Garofalo C., Surmacz E. Leptin and cancer. J Cell Physiol 2006, 207:12-22.
21. Rosenbaum M., Pietrobelli A., Vasselli J.R., Heymsfield S.B., Leibel R.L. Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution. Int J Obes Relat Metab Disord 2001, 25:1365-1371.
22. Cheng S.P., Chi C.W., Tzen C.Y., Yang T.L., Lee J.J., Liu T.P., et al. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery 2010, 147:847-853.
23. Weaver S., Doherty D.B., Jimenez C., Perrier N.D. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg 2009, 33:2292-2302.
24. McKinney K., Breitkopf C.R., Berenson A.B. Association of race, body fat and season with vitamin D status among young women: a cross-sectional study. Clin Endocrinol (Oxf) 2008, 69:535-541.
25. Need A.G., O'Loughlin P.D., Morris H.A., Horowitz M., Nordin B.E. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 2004, 89:1646-1649.
26. Vieth R., Bayley T.A., Walfish P.G., Rosen I.B., Pollard A. Relevance of vitamin D metabolite concentrations in supporting the diagnosis of primary hyperparathyroidism. Surgery 1991, 110:1043-1047.
27. Menendez C., Lage M., Peino R., Baldelli R., Concheiro P., Dieguez C., et al. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 2001, 170:425-431.
28. Matsunuma A., Kawane T., Maeda T., Hamada S., Horiuchi N. Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and 24-hydroxylase in leptin-deficient, ob/ob mice. Endocrinology 2004, 145:1367-1375.
29. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4:579-591.
30. Wong C.K., Lai T., White S., Sheffield E., Wheeler M.H., Stewart C.E., et al. Characterization of the insulin-like growth factor axis and Wilms' tumour suppressor gene in hyperparathyroidism. Br J Surg 2007, 94:1232-1241.
31. Lewandowski K., Randeva H.S., O'Callaghan C.J., Horn R., Medley G.F., Hillhouse E.W., et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol (Oxf) 2001, 54:533-539.
32. Liu C.L., Chang Y.C., Cheng S.P., Chern S.R., Yang T.L., Lee J.J., et al. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007, 72:75-81.